Hereditary hemorrhagic telangiectasia treated by laser surgery

Area of Science:

• Vascular Medicine
• Otolaryngology
• Dermatology

Background:

• Hereditary hemorrhagic telangiectasia (Osler's disease) is a rare genetic disorder characterized by abnormal blood vessel development.
• Severe epistaxis (nosebleeds) is the most prominent and debilitating symptom, significantly impacting patient quality of life.
• Traditional treatments like nasal dermoplasty have limitations, prompting investigation into alternative therapies.

Purpose of the Study:

• To evaluate the efficacy and safety of laser treatment for severe epistaxis in patients with Osler's disease.
• To compare the effectiveness of CO2-laser and argon laser therapies.
• To assess the convenience and repeatability of laser interventions for managing telangiectasias at various body sites.

Main Methods:

• Ten patients diagnosed with Osler's disease and experiencing severe epistaxis were enrolled.
• Treatment modalities included CO2-laser (under general anesthesia) and argon laser (under local anesthesia).
• Telangiectasias at other sites (mouth, face, fingers, rectum) were also treated concurrently.

Main Results:

• Eight out of ten patients achieved good results with laser therapy.
• The argon laser proved more convenient than the CO2 laser, allowing for outpatient treatment without hospitalization.
• Repeat treatments were necessary in three cases, with no permanent damage to nasal function observed.

Conclusions:

• Laser therapy, particularly with the argon laser, presents a quick, reliable, and repeatable treatment option for severe epistaxis in Osler's disease.
• This minimally invasive approach offers functional and cosmetic benefits with minimal downtime.
• The argon laser is a preferred modality due to its convenience and suitability for repeated application without compromising nasal function.